<DOC>
	<DOCNO>NCT00555204</DOCNO>
	<brief_summary>The purpose study test investigational medication ABT-089 safe effective treatment Alzheimer 's disease .</brief_summary>
	<brief_title>Safety Efficacy Study ABT-089 Adults With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Patient mild moderate Alzheimer 's disease Patient receive stable dose acetylcholinesterase inhibitor Patient MMSE score 12 26 Patient MHIS score less equal 4 Females must postmenopausal least two year surgically sterile Patient identify , reliable , caregiver support him/her ensure compliance treatment accompany outpatient visit Patient living nursing home Patient history significant neurologic disease Alzheimer 's disease Patient uncontrolled medical illness Patient use nonprescribed drug abuse history drug alcohol abuse/dependence</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>mild moderate Alzheimer 's disease , memory , cognition , dementia</keyword>
</DOC>